Ambulatory blood pressure devices are used to track the blood pressure levels among patients. These have emerged as user-friendly non-invasive devices that can monitor patients even while sleeping. ABPM monitors determine blood pressure by reading the pulse rate and can be worn on the arms or wrist.
The global market for the Ambulatory Blood Pressure Monitoring Devices is anticipated to develop at a compound annual growth rate (CAGR) of 6.97% throughout the course of the forecast, to reach $202.57 million by 2030.
Covid-19 Impact & Market Status:
The unexpected emergence of the COVID-19 pandemic has posed a threat to the worldwide healthcare system. According to current research, people with high blood pressure are more prone to get COVID-19 infections. High blood pressure is the major cause of hospitalisation, accounting for up to 30 percent to 50 percent of all patients, according to a rigorous analysis of data from both the United States and China. High BP will, in turn, boost the market's expansion, implying that it has had a favourable impact.
In 2020, the Arm ABPM devices segment had the most market share, and this trend is expected to continue during the years 2022-2029. It's a little digital blood pressure monitor that's attached to the patient's waist via a belt and connected to an upper arm cuff. It is portable and hence it has no time and location constraints. It also has a sleep monitoring feature that makes it highly desirable among end-users. Because of its great availability, accuracy, and general acceptability, the market for arm ABPM monitors is increasing. Additionally, rising healthcare costs, increased awareness of ABPM, and the availability of newer and more advanced arm ABPM devices are all projected to boost market growth in the near future.
North America had the biggest market share, followed by Europe. During the 2022-2029, Asia, is going to be the fastest-growing geographical segment. Fast-growing instances of lifestyle ailments, more specifically diabetes Mellitus and cardio diseases along with hypertension is identified to push the global ambulatory blood pressure monitoring devices market. Also, patient awareness and developing preferences for pain-free non-invasive medium for pressure monitoring is further helping the market expand. Due to the increased attention of important companies in emerging economies and improved healthcare infrastructure, Asia-Pacific is likely to emerge as the region with the greatest growth potential.
With a constant CAGR, the 'Hospitals' category led the market. The rising prevalence of BP, as well as increased government measures to enhance the health-care infrastructure in order to deliver a more patient-centered care system, are driving this market's expansion.
From 2022 to 2029, the global ambulatory blood pressure monitoring devices market is expected to grow at a CAGR of 6.7 percent, to reach over 168.91 billion by 2029.
The market is primarily driven by an increase in the number of hypertension cases as a result of rising diabetes, obesity, and cardiovascular disease prevalence. Furthermore, the increase in the geriatric population, the desire for non-invasive methods of measuring blood pressure, and the shift from a physician-centered to a patient-centered model are all factors driving the global ABPM devices market.
The ABPM Devices' higher adaptability is demonstrated by the ageing population and changing lifestyles, creating a lucrative prospect for growth. In addition, the United States and other emerging nations have seen enormous increases in healthcare infrastructure and investment, which will provide a favorable chance for substantial growth in the Ambulatory Blood Pressure Monitoring Devices Market over the anticipated period.
The global market is projected to be hampered by the high cost of ABPM equipment and a lack of awareness regarding ambulatory blood pressure in emerging countries and Until and unless disguised hypertension or white coat hypertension is suspected to be the principal cause limiting the market's growth, patients will not be reimbursed for utilising ambulatory devices.
The major market players of Ambulatory Blood Pressure Monitoring Devices Market are Spacelabs Healthcare, Inc., SunTech Medical, Contec Inc. (Parent Company: DAIFUKU CO., LTD.), Rudolf Riester GmbH, Vaso Corporation, Welch Allyn, Inc., Schiller AG, Bosch & Sohn GmbH & Co., GE Company and BPL Group.
Major Developments in Ambulatory Blood Pressure Monitoring Devices Market:
- Omron Ambulatory Blood Pressure Monitor is gaining popularity due to its TruRead technology, which provides clinically accurate findings. As a result, in the coming years, it is predicted to increase at an exponential rate.
- CMS has expanded its nationwide coverage of ABPM in two ways, based on recommendations from the AHA and AMA. The first is decreasing hypertension (BP) threshold from 140/90 to 130/80, allowing more patients to benefit from ABPM. The second is to make ABPM devices available to patients who are suspected of having lower-than-normal blood pressure readings in clinical examinations.
Ambulatory Blood Pressure Monitoring Devices Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||USD 168.91 billion.|
|Growth Rate||CAGR of 6.7% during 2021-2028|
|Segment Covered||By Type, By End User, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East & Africa|
|Key Players Profiled||Spacelabs Healthcare, Inc., SunTech Medical, Contec Inc. (Parent Company: DAIFUKU CO., LTD.), Rudolf Riester GmbH, Vaso Corporation, Welch Allyn, Inc., Schiller AG, Bosch & Sohn GmbH & Co. & among others.|
Key Segments of Ambulatory Blood Pressure Monitoring Devices Market
- By Type
- Arm ABPM Device
- Wrist ABPM Device
- By End User
- Ambulatory surgical centers
- By Region
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa